loadpatents
name:-0.015562057495117
name:-0.0097560882568359
name:-0.0038390159606934
GIBSON; Christoph Patent Filings

GIBSON; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for GIBSON; Christoph.The latest application filed is for "(r)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)- methyl)phenyl)morpholine derivatives and related compounds as bradykinin (bk) b2 receptor antagonist for treating skin diseases".

Company Profile
3.8.12
  • GIBSON; Christoph - Berlin DE
  • Gibson; Christoph - Ihringen DE
  • Gibson; Christoph - Munich DE
  • Gibson; Christoph - Munchen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
(r)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)- Methyl)phenyl)morpholine Derivatives And Related Compounds As Bradykinin (bk) B2 Receptor Antagonist For Treating Skin Diseases
App 20220289730 - GIBSON; Christoph ;   et al.
2022-09-15
Novel Bradykinin B2 Receptor Antagonists
App 20220135543 - GIBSON; Christoph ;   et al.
2022-05-05
1-((s)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-ylo- Xy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione Derivatives And Related Compounds As Bradykinin (bk) B2 Receptor Antagonist For Treating Skin Diseases
App 20220135542 - GIBSON; Christoph ;   et al.
2022-05-05
Bradykinin B2 receptor antagonists
Grant 11,261,173 - Gibson , et al. March 1, 2
2022-03-01
Novel Bradykinin B2 Receptor Antagonists
App 20210017158 - GIBSON; Christoph ;   et al.
2021-01-21
Bradykinin B2 receptor antagonists
Grant 10,836,748 - Gibson , et al. November 17, 2
2020-11-17
Novel Bradykinin B2 Receptor Antagonists
App 20200255405 - Kind Code
2020-08-13
8-oxy-quinoline derivatives as bradykinin B2 receptor modulators
Grant 8,410,134 - Gibson , et al. April 2, 2
2013-04-02
Compounds For The Inhibition Of Rotamases And Use Thereof
App 20110065760 - KNOLLE; Jochen ;   et al.
2011-03-17
8-oxy-quinoline Derivatives As Bradykinin B2 Receptor Modulators
App 20100234344 - Gibson; Christoph ;   et al.
2010-09-16
Peptide and peptide mimetic conjugates with integrin-inhibitor properties
Grant 7,655,624 - Meyer , et al. February 2, 2
2010-02-02
Kinin Antagonists For Treating Bladder Dysfunction
App 20080221039 - Gibson; Christoph ;   et al.
2008-09-11
Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
App 20080194524 - Knolle; Jochen ;   et al.
2008-08-14
Peptide and peptide mimetic derivatives with integrin-inhibitors properties II
Grant 7,276,482 - Meyer , et al. October 2, 2
2007-10-02
Phenol derivatives and their use as rotamase inhibitors
App 20070054904 - Knolle; Jochen ;   et al.
2007-03-08
Peptide and peptide mimetic derivatives with integrin-inhibitors properties II
App 20040043937 - Meyer, Jorg ;   et al.
2004-03-04
Peptide and peptide mimetic conjugates with integrin-inhibitor properties
App 20040029782 - Meyer, J?ouml;rg ;   et al.
2004-02-12
Diacylhydrazine derivatives
Grant 6,649,613 - Holzemann , et al. November 18, 2
2003-11-18
Diacylhydrazine derivatives as integrin inhibitors
Grant 6,326,403 - Holzemann , et al. December 4, 2
2001-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed